about
Landscape of genomic alterations in cervical carcinomas.Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.Characterization of HPV and host genome interactions in primary head and neck cancers.Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's Disease.Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma.Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaTumor fraction in cell-free DNA as a biomarker in prostate cancerStructural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome SequencingSensitive detection of minimal residual disease in patients treated for early-stage breast cancerAcquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapiesIdentification and characterization of an alternative cancer-derived PD-L1 splice variantGenomic and immune profiling of pre-invasive lung adenocarcinomaThe Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability
P50
Q34169464-F63E6A3F-457E-4870-8019-53856DAF1DC7Q34362427-76567604-C2DB-4900-8960-7E002006AED8Q34442327-26BFBBCF-C2BE-4EFE-B85E-9FA85CB86012Q35127765-1AA4B539-61EA-40D1-A060-EFC687854C77Q37297780-51B48498-242D-4113-A6C1-DC52CC4A4499Q38732657-7D56D5B8-97A1-465F-BA0E-33AFBFD33771Q38852406-6942E788-EB08-484E-A977-9515BB11FEB6Q41519401-E0F61E86-9A64-4DDA-B6D0-D9DEADA982FFQ43018762-D61E1B3D-5FDF-4DE0-B5D4-59D243E7EE50Q43045850-E1AA193D-6ADB-4160-B4E5-55221AB6540DQ46129222-4DB6F427-59EE-4EDC-B318-25F377916FE5Q47214510-8BF72B79-040E-45E2-971F-FE685381F1D9Q55312090-10C4088E-0CB7-4E62-9EBB-E7C867B1E692Q58547062-EC658C2F-524D-4961-9422-E270C9E3C713Q58617288-7B6A6BB8-2A92-40FA-B15E-4959FBC96B74Q89128842-4F658966-95C0-4722-B0C3-A8EF08496603Q90316165-5E6B15AF-9A81-441A-AF9F-8C4D29BD816FQ90371029-E662A33B-4242-4D31-B0B8-65888174C342Q90626079-96424A8B-72BC-4ABB-9A83-F5E7D22B9E8FQ91558572-7F180EAE-87CC-4BB3-88EA-EFFD0F5F36ECQ92244263-6F415E81-0366-494A-B778-ABCF5522FA0A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Samuel S Freeman
@ast
Samuel S Freeman
@en
Samuel S Freeman
@es
Samuel S Freeman
@nl
Samuel S Freeman
@sl
type
label
Samuel S Freeman
@ast
Samuel S Freeman
@en
Samuel S Freeman
@es
Samuel S Freeman
@nl
Samuel S Freeman
@sl
prefLabel
Samuel S Freeman
@ast
Samuel S Freeman
@en
Samuel S Freeman
@es
Samuel S Freeman
@nl
Samuel S Freeman
@sl
P106
P21
P31
P496
0000-0001-8285-0057